COMP <GO>
RDNT vs JNJ // ALTMAN Z-SCORE & DEBT/EQUITY
RadNet Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: RDNT 2
— JNJ 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: JNJ
LAST: $73.49 (-0.22%) • MKT CAP: $5.78B
balance-sheet
2.15
LAST: $273.20 (-0.73%) • MKT CAP: $657.68B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RDNT VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RDNT | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.50% | 25.50% | -22.00 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 98.3x | 18.5x | +79.80 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 5.16% | 2.97% | +2.19 | RDNT | /fcf-yield <GO> |
| Operating Margin | 3.00% | 34.70% | -31.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -0.90% | 28.50% | -29.40 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 11.50% | 6.00% | +5.50 | RDNT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.15 | 5.59 | -3.44 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.9 | 59.1 | -1.20 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.78B | $657.68B | -$651.89B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RDNT REV | JNJ REV | RDNT GROSS % | JNJ GROSS % | RDNT FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.04B | $94.19B | — | 67.9% | $298.8M | $19.70B |
| FY 2024 | $1.83B | $88.82B | — | 69.1% | $233.0M | $19.84B |
| FY 2023 | $1.62B | $85.16B | — | — | $220.9M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RDNT // BETA —
JNJ // BETA 1.08